Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study.
Takao TakeshimaHikaru DoiSatomi OobaYuka TanjiAkichika OzekiMika KomoriPublished in: Neurology and therapy (2024)
ClinicalTrials.gov, NCT02959177 and NCT02959190.